184 related articles for article (PubMed ID: 10667333)
1. Respective roles of the 14 kDa and 85 kDa phospholipase A2 enzymes in human monocyte eicosanoid formation.
Marshall LA; Bolognese B; Roshak A
Adv Exp Med Biol; 1999; 469():215-9. PubMed ID: 10667333
[TBL] [Abstract][Full Text] [Related]
2. Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation.
Marshall LA; Bolognese B; Winkler JD; Roshak A
J Biol Chem; 1997 Jan; 272(2):759-65. PubMed ID: 8995361
[TBL] [Abstract][Full Text] [Related]
3. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
[TBL] [Abstract][Full Text] [Related]
4. Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils.
Flamand N; Picard S; Lemieux L; Pouliot M; Bourgoin SG; Borgeat P
Br J Pharmacol; 2006 Oct; 149(4):385-92. PubMed ID: 16967052
[TBL] [Abstract][Full Text] [Related]
5. Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages.
Shamsuddin M; Chen E; Anderson J; Smith LJ
J Lab Clin Med; 1997 Dec; 130(6):615-26. PubMed ID: 9422335
[TBL] [Abstract][Full Text] [Related]
6. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
[TBL] [Abstract][Full Text] [Related]
7. Suppression of monocyte 85-kDa phospholipase A2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis.
Roshak A; Sathe G; Marshall LA
J Biol Chem; 1994 Oct; 269(42):25999-6005. PubMed ID: 7929310
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic 85-kDa phospholipase A2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells.
Anderson KM; Roshak A; Winkler JD; McCord M; Marshall LA
J Biol Chem; 1997 Nov; 272(48):30504-11. PubMed ID: 9374544
[TBL] [Abstract][Full Text] [Related]
9. Effects of granulocyte-macrophage colony-stimulating factor on eicosanoid production by mononuclear phagocytes.
Brock TG; McNish RW; Coffey MJ; Ojo TC; Phare SM; Peters-Golden M
J Immunol; 1996 Apr; 156(7):2522-7. PubMed ID: 8786314
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase A2.
Murakami M; Kudo I
J Biochem; 2002 Mar; 131(3):285-92. PubMed ID: 11872155
[TBL] [Abstract][Full Text] [Related]
11. Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets.
Riendeau D; Guay J; Weech PK; Laliberté F; Yergey J; Li C; Desmarais S; Perrier H; Liu S; Nicoll-Griffith D
J Biol Chem; 1994 Jun; 269(22):15619-24. PubMed ID: 8195210
[TBL] [Abstract][Full Text] [Related]
12. Functional consequences of phospholipase A2 activation in human monocytes.
Hoffman T; Brando C; Lizzio EF; Lee C; Hanson M; Ting K; Kim YJ; Abrahamsen T; Puri J; Bonvini E
Adv Exp Med Biol; 1990; 279():125-36. PubMed ID: 1965768
[TBL] [Abstract][Full Text] [Related]
13. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase A2 enzymes.
Kudo I; Murakami M
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():3-58. PubMed ID: 12432908
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of arachidonoyl trifluoromethyl ketone on arachidonic acid release and lipid mediator biosynthesis by human neutrophils. Evidence for different arachidonate pools.
Fonteh AN
Eur J Biochem; 2002 Aug; 269(15):3760-70. PubMed ID: 12153573
[TBL] [Abstract][Full Text] [Related]
16. VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2.
Bernatchez PN; Winstead MV; Dennis EA; Sirois MG
Br J Pharmacol; 2001 Sep; 134(1):197-205. PubMed ID: 11522612
[TBL] [Abstract][Full Text] [Related]
17. Cytosolic phospholipase A2-mediated regulation of phospholipase D2 in leukocyte cell lines.
Kim JH; Lee BD; Kim Y; Lee SD; Suh PG; Ryu SH
J Immunol; 1999 Nov; 163(10):5462-70. PubMed ID: 10553072
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.
Ribaldi E; Mezzasoma AM; Francescangeli E; Prosdocimi M; Nenci GG; Goracci G; Gresele P
Br J Pharmacol; 1996 Jul; 118(6):1351-8. PubMed ID: 8832056
[TBL] [Abstract][Full Text] [Related]
19. Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor.
Fonteh AN; Samet JM; Chilton FH
J Clin Invest; 1995 Sep; 96(3):1432-9. PubMed ID: 7544805
[TBL] [Abstract][Full Text] [Related]
20. Human calcium-independent phospholipase A2 mediates lymphocyte proliferation.
Roshak AK; Capper EA; Stevenson C; Eichman C; Marshall LA
J Biol Chem; 2000 Nov; 275(46):35692-8. PubMed ID: 10964913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
